Skip to content

Clinical trials

Phase 1/2 Breast Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Country / region: Israel Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20101
20161
20172
20181
20191
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting3
Completed3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hadassah Medical Organization2
Hoffmann-La Roche2
AstraZeneca1
Eli Lilly and Company1
Merck Sharp & Dohme LLC1
Michael Har-Noy1
Novartis Pharmaceuticals1
Shaare Zedek Medical Center1
Sheba Medical Center1
Stemline Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms12
Ovarian Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Lung Neoplasms2
Melanoma2
Small Cell Lung Carcinoma2
Stomach Neoplasms2
Bronchial Neoplasms1
Carcinoma1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.